Financhill
Sell
27

RZLT Quote, Financials, Valuation and Earnings

Last price:
$3.21
Seasonality move :
-0.96%
Day range:
$3.09 - $3.35
52-week range:
$1.07 - $11.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.40x
Volume:
2.5M
Avg. volume:
2.8M
1-year change:
-24.29%
Market cap:
$307.2M
Revenue:
--
EPS (TTM):
-$0.92

Analysts' Opinion

  • Consensus Rating
    Rezolute, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $4.75, Rezolute, Inc. has an estimated upside of 47.98% from its current price of $3.21.
  • Price Target Downside
    According to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $3.21.

Fair Value

  • According to the consensus of 9 analysts, Rezolute, Inc. has 47.98% upside to fair value with a price target of $4.75 per share.

RZLT vs. S&P 500

  • Over the past 5 trading days, Rezolute, Inc. has underperformed the S&P 500 by -2% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Rezolute, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Rezolute, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Rezolute, Inc. reported revenues of --.

Earnings Growth

  • Rezolute, Inc. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Rezolute, Inc. reported earnings per share of -$0.22.
Enterprise value:
175.5M
EV / Invested capital:
1.36x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-7.65x
EV / Free cash flow:
-2.28x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$30K
Return On Assets:
-61.98%
Net Income Margin (TTM):
--
Return On Equity:
-67.99%
Return On Invested Capital:
-67.11%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue -- -- -- -- --
Gross Profit -$280K -$32K -$30K -$8K -$7K
Operating Income -$62.5M -$73.3M -$89.9M -$17.1M -$24.2M
EBITDA -$62.2M -$73.3M -$89.9M -$17.1M -$24.2M
Diluted EPS -$1.11 -$1.22 -$0.92 -$0.22 -$0.22
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $78.1M $147.6M $96.1M $98.7M $135.1M
Total Assets $83.4M $150.2M $102.2M $112M $138.6M
Current Liabilities $6.4M $6.3M $8M $10.6M $9.5M
Total Liabilities $21.1M $8.9M $10.4M $12.4M $10.6M
Total Equity $62.3M $141.3M $91.7M $99.6M $128M
Total Debt $14.3M $2.2M $2M $1.3M $619K
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations -$53M -$63.4M -$77.1M -$13.7M -$20.3M
Cash From Investing -$80.9M -$9.6M -$22.3M $11.5M $22.8M
Cash From Financing -$293K $69.5M $102.4M $657K $356K
Free Cash Flow -$53M -$63.4M -$77.1M -$13.7M -$20.3M
RZLT
Sector
Market Cap
$307.2M
$25.5M
Price % of 52-Week High
28.02%
50%
Dividend Yield
0%
0%
Shareholder Yield
-45.36%
-1.62%
1-Year Price Total Return
-24.29%
-18.12%
Beta (5-Year)
0.463
0.496
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.38
200-day SMA
Sell
Level $5.91
Bollinger Bands (100)
Sell
Level 2.55 - 9.31
Chaikin Money Flow
Sell
Level -2.2M
20-day SMA
Sell
Level $3.32
Relative Strength Index (RSI14)
Sell
Level 46.55
ADX Line
Sell
Level 22.57
Williams %R
Neutral
Level -77.4443
50-day SMA
Buy
Level $2.87
MACD (12, 26)
Buy
Level 0.93
25-day Aroon Oscillator
Buy
Level 24
On Balance Volume
Sell
Level -6.1M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (13.786)
Sell
CA Score (Annual)
Level (-0.8811)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (8.8058)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Stock Forecast FAQ

In the current month, RZLT has received 5 Buy ratings 4 Hold ratings, and 0 Sell ratings. The RZLT average analyst price target in the past 3 months is $4.75.

  • Where Will Rezolute, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Rezolute, Inc. share price will rise to $4.75 per share over the next 12 months.

  • What Do Analysts Say About Rezolute, Inc.?

    Analysts are divided on their view about Rezolute, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rezolute, Inc. is a Sell and believe this share price will drop from its current level to $2.00.

  • What Is Rezolute, Inc.'s Price Target?

    The price target for Rezolute, Inc. over the next 1-year time period is forecast to be $4.75 according to 9 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is RZLT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Rezolute, Inc. is a Buy. 5 of 9 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of RZLT?

    You can purchase shares of Rezolute, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rezolute, Inc. shares.

  • What Is The Rezolute, Inc. Share Price Today?

    Rezolute, Inc. was last trading at $3.21 per share. This represents the most recent stock quote for Rezolute, Inc.. Yesterday, Rezolute, Inc. closed at $3.21 per share.

  • How To Buy Rezolute, Inc. Stock Online?

    In order to purchase Rezolute, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
54
AAOI alert for Feb 28

Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.

Buy
90
BNAI alert for Feb 28

Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.

Sell
36
WLDN alert for Feb 28

Willdan Group, Inc. [WLDN] is down 25.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock